MS: New drug proven to slow brain shrinkage
A new clinical trial for the drug ibudilast offers much-needed hope for people living with multiple sclerosis — a neurological condition that affects primarily women and has limited treatment options. Using MRI scans, researchers were able to see that the new drug slows down brain shrinkage in people with MS. The results of the trial,…